Yahoo Search Búsqueda en la Web

Entrar

Resultado de búsqueda

  1. pubmed.ncbi.nlm.nih.gov › 35390769Management of Immunotherapy-Related Toxicities, Version 1.2022,...

    31 National Comprehensive Cancer Network. PMID: 35390769. DOI: 10.6004/jnccn.2022.0020. Abstract. The aim of the NCCN Guidelines for Management of Immunotherapy-Related Toxicities is to provide guidance on the management of immune-related adverse events resulting from cancer immunotherapy.

  2. jnccn.org › view › journalsNCCN Guidelines Insights: Management of Immunotherapy-Related ...

    1 de mar. de 2020 · The NCCN Guidelines for Management of Immunotherapy-Related Toxicities provide interdisciplinary guidance on the management of immune-related adverse events (irAEs) resulting from cancer immunotherapy.

  3. www.ic-onc.org › pdfs › management_of_immunotherapy-related_toxicities(Version1NCCN Clinical Practice Guidelines in ncology (NCCN Guidelines ...

    NCCN Guidelines® and this illustration may not be reproduced in any form without the express written permission of NCCN. NCCN Clinical Practice Guidelines in ncology (NCCN Guidelines ®) Management of Immunotherapy‑Related Toxicities Version 1.2020 — December 16, 2019 Continue NCCN.org

  4. jnccn.org › view › journalsManagement of Immunotherapy-Related Toxicities, Version 1.2019,...

    11 de mar. de 2019 · FULL TEXT. PDF. ARTICLE DETAILS. The aim of the NCCN Guidelines for Management of Immunotherapy-Related Toxicities is to provide guidance on the management of immune-related adverse events resulting from cancer immunotherapy.

  5. www.ncbi.nlm.nih.gov › pmc › articlesHypersensitivity Reactions to Platinum Agents and Taxanes

    2 de ago. de 2021 · Severe reactions occurred in up to 7% of the patients who underwent either platin or taxane DPT , and the authors emphasize that while DPT can be used as a diagnostic tool with careful patient selection and risk assessment, it is a high-risk procedure that requires specialized resources, monitoring, and expert allergy care .

  6. www.nccn.org › docs › default-sourceUnderstanding Immunotherapy Side Effects - NCCN

    effects from immunotherapy can affect your whole body. • Side effects may appear shortly after beginning treatment, within the first couple of months, or even after you finish treatment. • Because many of these side effects can occur from other causes that would be treated differently, make sure your doctor knows you are or were on

  7. pubmed.ncbi.nlm.nih.gov › 32135517NCCN Guidelines Insights: Management of Immunotherapy-Related ......

    The NCCN Guidelines for Management of Immunotherapy-Related Toxicities provide interdisciplinary guidance on the management of immune-related adverse events (irAEs) resulting from cancer immunotherapy. These NCCN Guidelines Insights describe symptoms that may be caused by an irAE and should trigger …